Skip to main content
Caplight Logo









LYZZ Capital

LYZZ Capital

Shanghai, Shanghailyzzcap.com

Overview

LYZZ Capital is a leading global healthcare-dedicated VC/PE firm that is actively investing out of USD and RMB funds totaling over USD$600 million . The LYZZ team is composed of highly experienced investment and operating professionals from leading pharmaceutical/biotech companies and Wall Street firms with strong scientific and medical professional backgrounds . They invest in talents, assets, and technologies globally, with an emphasis on unmet medical needs and large market potential in China .

Year Founded

2014

AUM

$600M

Portfolio Companies

9

Investments

LYZZ Capital investments
CompanyDateStageLead
Nanjing Zenshine Pharmaceuticals Co., Ltd.Jun 2021Series A ExtensionCo-investor
Beijing Lidakang Technology Co., Ltd.Oct 2020VC RoundCo-investor
Beijing Lidakang Technology Co., Ltd.Oct 2020VC RoundCo-investor
Allotera TherapeuticsAug 2025Series CCo-investor
Mojia BioJun 2022Series BCo-investor
Book a demo to see all investments

For institutional investors. Book with your work email.

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Book a demo to explore sector, stage, and valuation breakdowns for this investor.

Book a demo

For institutional investors. Book with your work email.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Book a demo to explore yearly investment trends and funding raised over time.

Book a demo

For institutional investors. Book with your work email.

FAQ

Where is LYZZ Capital based?

LYZZ Capital is headquartered in Shanghai, Shanghai, China.

When was LYZZ Capital founded?

LYZZ Capital was founded in 2014.

How many portfolio companies does LYZZ Capital have?

LYZZ Capital has 9 portfolio companies in Caplight's dataset.

What are some companies in LYZZ Capital's portfolio?

Portfolio companies visible on Caplight include Nanjing Zenshine Pharmaceuticals Co., Ltd., Beijing Lidakang Technology Co., Ltd., Beijing Lidakang Technology Co., Ltd., Allotera Therapeutics, Mojia Bio.

What was LYZZ Capital's most recent investment shown here?

LYZZ Capital's most recent investment in this portfolio sample was in Allotera Therapeutics in 2025.

What sectors does LYZZ Capital focus on?

LYZZ Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Energy & Sustainability, Frontier & Industrial Tech.

What company stages does LYZZ Capital focus on?

LYZZ Capital typically invests at the MultiStage stage.

What is LYZZ Capital's AUM?

LYZZ Capital's assets under management are estimated between $500.0M and $1.0B.

Firmographic Details

HeadquartersShanghai, Shanghai
Year Founded2014
AUM$600M

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?